Blue Chips
Measuring Success
Go To Market
Key Initiatives
People
100
*Deliver on our customer and client commitments *Enable more affordable economics for our customers *Proactively serve segments through flexible products, pricing and reporting *Work closely with clinical partners to drive enhanced health outcomes for our customers *Enhance consumer engagement through pharmacy channels to create value for customers and improve the relationship with Cigna
What are CPM Strategic Priorities
100
The Catamaran sourcing agreement has had the biggest impact on these 2 current earnings drivers - contributing to the 2014 Total BFIT Margin or $1B
What are Retail Spread and Rebates
100
While CPM: Lowers total health care costs and Manages 100% Specialty Rx costs, traditional PBMs focus only on this (category of cost)
What is drug cost
100
While the first stage of Integrated Value work is focused on Cigna Pharmacy Management opportunities -(leveraging inbound Rx customer calls to engage on drug and/or channel switch) subsequent stages will involve referrals to CPM from this area
What is Consumer Health Engagement
100
An avid golfer, our new SRx Product Manager, who comes to us most recently from UHG
Who is Jane Boston
200
2 areas of focus or "blue chips" related to the CPM priority "Work closely with clinical partners to drive enhanced health outcomes for our customers"
What are: 1) Advance Specialty Rx 2) Advance Insights That Matter 3) Start transforming Clinical Practice 4) Advance integration value to customers
200
2 current opportunities identified (as of 1Q 2014) to help meet our 2014 SRx Earnings Plan of $133 M, 347k scripts
What are: 1) Retail Specialty Contract Management (6/1/2014) 2) Multiple Sclerosis Therapeutic Class Strategy 3) Enhanced Customer Directed SRx/Marketing Campaigns
200
2 examples of how CPM uses pharmacy and medical information to optimize outcomes
What are: 1) One CoachRx pharmacist and health coach team share assets through HealthEview and coach on whole condition 2) Medical data helps us facilitate and auto-pay prior authorizations to increase medication adherence and reward high performing doctors 3) Embedded Care Coordinators (Cigna Collaborative Accountable Care) connect customers to CoachRx/TheraCare 4) Drug therapy part of UM
200
2 initiatives on the Customer Acquisition/Retention team Roadmap
What are: Quickfill Assess refill reminders Campaign management/migrate to platform Specialty - Refine SRx EHD, onboarding, add autorefill, add to Rx SM, leverage medical
200
Within the CPM PMO, our new SRx Program Manager, comes to us most recently from The Hartford; In addition to 5 kids, has a dog, 2 rabbits, 22 fish, 10,000 bees and chickens/ducks/a cockatiel
Who is David Breitsprecher
300
The Enabling Blue chip related to the following ICS APOs: Deliver on foundational clinical operating model and infrastructure to support long term Catamaran relationship – focused on clinical innovation to improve THC and Health Deliver on Clinical migration pilots in late 2014 and position for successful 2015 full migration Determine how Catamaran may accelerate our Specialty Rx and Customer Engagement strategies and implement specific roadmap
What is Accel Rx Execution
300
2 of the key "accountabilities" or strategies driving our 2014 clinical practice transformation approach and an example action for each
What are : 1) Time to optimal therapy (strategy/action: coordinated authorization and fulfillment process, enrich step therapy with individually relevant information ) 2) Total Cost Impact (Substantial: Integrated POS environment Rx-Medical P4P network collaboration Integrated consumer health engagement ACOs with Rx Adherence) 3) Total Health Improvement (integrated consumer health engagement, focus areas to accelerate adherence- 15% increase in Theracare/Coach Rx engagement,10% YOY improvement in clinical metrics)
300
2 Examples of what makes Cigna SRx different compared to traditional PBMs
What are: 360-degree health insight and support to drive total health 3-4% UM savings under both medical and pharmacy benefits1 Deep discounts across plans: -30% AWP for medical2 -16% AWP for pharmacy Full-strength critical connection between all our key stakeholders $27.5M saved by working with doctors and 400 customers to guide specialty drug administration to most clinically effective care site4 Innovative incentive-based contracts that drive health ownership Total management of care and costs – not just the drug TheraCare and condition-specific teams Collaboration on drug choice and infusion site to reduce cost
300
Reduce medical cost and share resulting savings among customers / clients, providers and Cigna Engage providers in value-based relationships and connect customers in health engagement Create integrated end-to-end capabilities that will enhance our position at the local market level
What are Volume to Value business objectives
300
These team members recently joined the organization to provide assistance on the ICS Financial team; One is a swim instructor
Who are Matt Grzyb and Anne Stevens
400
Customer Acquisition/Retention activity including (the pillars of) 1) engaging the right customer, 2) at the right time, 3) for the desired behavior support the following CPM blue chips and/or priorities
What are: Hit earnings plan (enable more affordable economics for our customers) Advance integration value to customers (Enhance consumer engagement through pharmacy channels to create value for customers and improve the relationship with Cigna)
400
3 of the targeted goals for our Health Improvement Scorecard (and an example)
What are: What are: 1) improve biometric control, 2) Avoid acute medical events 3) Slow the progression of chronic illness and 4) Avoid disabling events
400
CPM's biggest (carrier) competitor
What is Optum
400
Specialty pharmacy strategy projects focus on aligning incentives as related to the followed 3 bands:
What are: 1) Preferred Specialty Pharmacy 2)Preferred Drug Selection 3) Preferred Physician/Facility Selection
400
These additions to the ICS team will be responsible for driving execution of key outreach initiatives to engage pharmacy customers in desired behaviors; Both bring customer orientation and valuable direct marketing expertise; One bowled for the first time last night
Who are Venecia Alfonso and Jill Scarpo
500
3 Ways to apply the CPM priority of "deliver on customer/client commitments" to ICS
What are: Operate a Reliable/efficient/stable business (SRX, PSC, UM and Campaigns) Execute on the basics (Programs, Operations and Coaching Especially exclusive SRX HD and PSC) Customer-centric (Wants and needs (known & unknown) Connect with other Enterprise support) Bring issues to resolution in timely manner (Don’t wait for “fire” Leverage “reliability process” Follow-up and follow through) Build long-term relationships (Consultative approach PG performance Do our part in AccelRx & Seniors integration Performance details: Achieve SRX NPS of +52 for FY Achieve smooth HealthSpring transition Improve health engagement with CHE Develop/embed Insights That Matter Develop enhanced “viewpoint” sharing Achieve our SRX and UM KPIs Support GTM/Segments with key bids
500
3 things we need to drive to achieve future CPM earnings
What are: 1) Drive Medical Membership Growth 2) Drive Pharmacy Penetration 3) Drive Integrated Specialty/Clinical Strategy 4) Drive Go to Market Strategies
500
While the Enhanced Value Drug list will continue to: drive generics through tier structure and apply clinical programs to reduce cost further: (Step Therapy Member Pay Difference logic) the following enhancement (to the Value Drug List) will apply:
What is Increasing amount of Preferred Brands (PB) and still maintaining savings Increasing number of PBs in these drug classes: OAB, cholesterol, testosterone, asthma, COPD, eye conditions, anticoagulant, oral diabetes, test strips, TNFs, and tetracyclines
500
3 examples of "round 2" specialty strategy projects
What are: Product focus: Integrated Benefit Design and Incentives across Pharmacy and Medical Physician Focus: Enhanced Specialty Steerage Program Enhanced Specialty Physician Incentives Specialty Condition Oriented Cost Contracting Customer Focus: Enhanced Specialty Customer Education & Decision Tools Specialty Customer Risk Profiling Customer Experience Enhancement Biosimilar Contracting Preparation
500
These 2 clinical pharmacists joined the Clinical team last fall, focused on pharmacy claim enhancements and drug list development/maintenance respectively
What is Who are Michelle Schrecengost-Kibbey and Michael Guren
M
e
n
u